XOMA Royalty (XOMA) Change in Accured Expenses (2010 - 2026)

XOMA Royalty (XOMA) reported Change in Accured Expenses of -$2.6 million for Q1 2026, up 19.51% on a YoY basis from -$2.2 million in Q1 2025, and up 64.24% sequentially from -$7.3 million in Q4 2025.

XOMA Royalty (XOMA) Change in Accured Expenses (2010 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 17 years of Change in Accured Expenses data on file, last reported at -$2.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Accured Expenses rose 19.51% year-over-year to -$2.6 million; the trailing twelve-month figure through Mar 2026 stood at -$10.4 million (down 563.51% YoY), and the FY2025 full-year result was -$10.6 million, down 763.14% from the prior year.
  • Change in Accured Expenses climbed to -$2.6 million in Q1 2026, from -$7.3 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $3.1 million in Q1 2023 to a low of -$7.3 million in Q4 2025.
  • A 5-year average of -$465250.0 and a median of $38000.0 in 2022 frame the typical range for Change in Accured Expenses.
  • Across the five-year window, Change in Accured Expenses surged 9403.23% in 2024 and tumbled 3009.52% in 2025, its largest moves.
  • Tracing XOMA's Change in Accured Expenses over 5 years: stood at $1.2 million in 2022, then plunged by 97.52% to $31000.0 in 2023, then surged by 9403.23% to $2.9 million in 2024, then plunged by 349.46% to -$7.3 million in 2025, then surged by 64.24% to -$2.6 million in 2026.
  • Business Quant data shows XOMA's Change in Accured Expenses at -$2.6 million in Q1 2026, -$7.3 million in Q4 2025, and $2.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 1.13 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 931,000.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -16.74 Mn
10 XOMA Royalty 478.42 Mn 412.34 Mn - -2.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.63 Mn
Mar 31, 2026 -2.63 Mn
Dec 31, 2025 -7.35 Mn
Dec 31, 2025 -7.35 Mn
Jun 30, 2025 2.88 Mn
Jun 30, 2025 2.88 Mn
Mar 31, 2025 -3.27 Mn
Mar 31, 2025 -3.27 Mn
Dec 31, 2024 2.95 Mn
Dec 31, 2024 2.95 Mn
Sep 30, 2024 -2.27 Mn
Sep 30, 2024 -2.27 Mn
Jun 30, 2024 1.03 Mn
Jun 30, 2024 1.03 Mn
Mar 31, 2024 -105,000.00
Mar 31, 2024 -105,000.00
Dec 31, 2023 31,000.00
Dec 31, 2023 31,000.00
Sep 30, 2023 215,000.00
Sep 30, 2023 215,000.00